nodes	percent_of_prediction	percent_of_DWPC	metapath
Dexmethylphenidate—SLC6A2—Clonidine—glaucoma	0.15	0.292	CbGbCtD
Dexmethylphenidate—CYP2D6—Carteolol—glaucoma	0.122	0.237	CbGbCtD
Dexmethylphenidate—CYP2D6—Betaxolol—glaucoma	0.0822	0.16	CbGbCtD
Dexmethylphenidate—CYP2D6—Methazolamide—glaucoma	0.0623	0.121	CbGbCtD
Dexmethylphenidate—CYP2D6—Timolol—glaucoma	0.053	0.103	CbGbCtD
Dexmethylphenidate—CYP2D6—Clonidine—glaucoma	0.0451	0.0876	CbGbCtD
Dexmethylphenidate—SLC6A3—Dopaminergic Neurogenesis—LMX1B—glaucoma	0.00337	0.0797	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—Na+/Cl- dependent neurotransmitter transporters—SLC6A13—glaucoma	0.00247	0.0585	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Na+/Cl- dependent neurotransmitter transporters—SLC6A13—glaucoma	0.00219	0.0518	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—Na+/Cl- dependent neurotransmitter transporters—SLC6A1—glaucoma	0.00181	0.0428	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—Amine compound SLC transporters—SLC6A13—glaucoma	0.00171	0.0406	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Na+/Cl- dependent neurotransmitter transporters—SLC6A1—glaucoma	0.0016	0.0379	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Amine compound SLC transporters—SLC6A13—glaucoma	0.00152	0.0359	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—Circadian rythm related genes—ATOH7—glaucoma	0.0015	0.0355	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—Monoamine Transport—SLC6A1—glaucoma	0.00139	0.0328	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—Amine compound SLC transporters—SLC6A1—glaucoma	0.00126	0.0297	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—Monoamine Transport—SLC6A1—glaucoma	0.00119	0.0282	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—SIDS Susceptibility Pathways—LMX1B—glaucoma	0.00118	0.028	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Amine compound SLC transporters—SLC6A1—glaucoma	0.00111	0.0263	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Monoamine Transport—SLC6A1—glaucoma	0.00106	0.025	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A13—glaucoma	0.000671	0.0159	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—Circadian rythm related genes—OPN4—glaucoma	0.000597	0.0141	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A13—glaucoma	0.000594	0.0141	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—NRF2 pathway—SLC6A13—glaucoma	0.000562	0.0133	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A1—glaucoma	0.000491	0.0116	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—NRF2 pathway—SLC6A13—glaucoma	0.000484	0.0114	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Tamoxifen metabolism—CYP1B1—glaucoma	0.00048	0.0114	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—NRF2 pathway—TXN—glaucoma	0.000462	0.0109	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Alpha-synuclein signaling—BAD—glaucoma	0.00046	0.0109	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—SLC-mediated transmembrane transport—SLC4A4—glaucoma	0.000457	0.0108	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A1—glaucoma	0.000435	0.0103	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—NRF2 pathway—SLC6A13—glaucoma	0.000428	0.0101	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—SIDS Susceptibility Pathways—HDAC9—glaucoma	0.000424	0.01	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—NRF2 pathway—SLC6A1—glaucoma	0.000412	0.00974	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—SLC-mediated transmembrane transport—SLC4A4—glaucoma	0.000405	0.00957	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—NRF2 pathway—TXN—glaucoma	0.000397	0.00939	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Melatonin metabolism and effects—CYP1B1—glaucoma	0.000371	0.00878	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—NRF2 pathway—SLC6A1—glaucoma	0.000354	0.00837	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—NRF2 pathway—TXN—glaucoma	0.000352	0.00832	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—Transmembrane transport of small molecules—PEX19—glaucoma	0.000344	0.00813	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—NRF2 pathway—TGFB2—glaucoma	0.000336	0.00794	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transmission across Chemical Synapses—SLC6A13—glaucoma	0.000333	0.00788	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—NRF2 pathway—SLC6A1—glaucoma	0.000314	0.00742	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—SLC-mediated transmembrane transport—SLC6A13—glaucoma	0.000305	0.00721	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transmembrane transport of small molecules—PEX19—glaucoma	0.000304	0.0072	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—SIDS Susceptibility Pathways—NTRK2—glaucoma	0.000304	0.00718	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Melatonin metabolism and effects—EDN1—glaucoma	0.0003	0.0071	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—Monoamine Transport—TNF—glaucoma	0.000292	0.00692	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—NRF2 pathway—TGFB2—glaucoma	0.000289	0.00683	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—SLC-mediated transmembrane transport—SLC6A13—glaucoma	0.00027	0.00639	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—NRF2 pathway—TGFB2—glaucoma	0.000256	0.00605	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Neuronal System—SLC6A13—glaucoma	0.000255	0.00604	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—Monoamine Transport—TNF—glaucoma	0.000251	0.00595	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Melatonin metabolism and effects—APOE—glaucoma	0.000244	0.00577	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transmission across Chemical Synapses—SLC6A1—glaucoma	0.000244	0.00577	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.000232	0.00549	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—NRF2 pathway—GSTM1—glaucoma	0.000228	0.0054	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—SIDS Susceptibility Pathways—BDNF—glaucoma	0.000227	0.00536	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—SLC-mediated transmembrane transport—SLC6A1—glaucoma	0.000223	0.00528	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Monoamine Transport—TNF—glaucoma	0.000223	0.00527	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—SIDS Susceptibility Pathways—IL1A—glaucoma	0.000218	0.00515	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—Circadian rythm related genes—NGFR—glaucoma	0.000213	0.00503	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.000207	0.00491	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.000206	0.00486	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.000205	0.00484	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—Circadian rythm related genes—NTRK1—glaucoma	0.000202	0.00478	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—SIDS Susceptibility Pathways—NGF—glaucoma	0.000201	0.00476	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—SIDS Susceptibility Pathways—NR3C1—glaucoma	0.0002	0.00473	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—SLC-mediated transmembrane transport—SLC6A1—glaucoma	0.000198	0.00467	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—NRF2 pathway—GSTM1—glaucoma	0.000196	0.00464	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Neuronal System—SLC6A1—glaucoma	0.000187	0.00442	CbGpPWpGaD
Dexmethylphenidate—Feeling abnormal—Travoprost—glaucoma	0.000184	0.000416	CcSEcCtD
Dexmethylphenidate—Conjunctivitis—Timolol—glaucoma	0.000184	0.000415	CcSEcCtD
Dexmethylphenidate—Gastrointestinal pain—Dorzolamide—glaucoma	0.000184	0.000415	CcSEcCtD
Dexmethylphenidate—Alopecia—Betaxolol—glaucoma	0.000184	0.000414	CcSEcCtD
Dexmethylphenidate—Palpitations—Clonidine—glaucoma	0.000184	0.000414	CcSEcCtD
Dexmethylphenidate—Gastrointestinal disorder—Pilocarpine—glaucoma	0.000183	0.000414	CcSEcCtD
Dexmethylphenidate—Gastrointestinal pain—Travoprost—glaucoma	0.000183	0.000413	CcSEcCtD
Dexmethylphenidate—Loss of consciousness—Clonidine—glaucoma	0.000183	0.000412	CcSEcCtD
Dexmethylphenidate—Feeling abnormal—Brinzolamide—glaucoma	0.000182	0.000411	CcSEcCtD
Dexmethylphenidate—Mental disorder—Betaxolol—glaucoma	0.000182	0.000411	CcSEcCtD
Dexmethylphenidate—Pain—Pilocarpine—glaucoma	0.000182	0.00041	CcSEcCtD
Dexmethylphenidate—Constipation—Pilocarpine—glaucoma	0.000182	0.00041	CcSEcCtD
Dexmethylphenidate—Cough—Clonidine—glaucoma	0.000181	0.000409	CcSEcCtD
Dexmethylphenidate—Sweating—Timolol—glaucoma	0.000181	0.000409	CcSEcCtD
Dexmethylphenidate—Dizziness—Apraclonidine—glaucoma	0.000181	0.000409	CcSEcCtD
Dexmethylphenidate—Malnutrition—Betaxolol—glaucoma	0.000181	0.000408	CcSEcCtD
Dexmethylphenidate—Erythema—Betaxolol—glaucoma	0.000181	0.000408	CcSEcCtD
Dexmethylphenidate—Urticaria—Dorzolamide—glaucoma	0.000178	0.000403	CcSEcCtD
Dexmethylphenidate—Epistaxis—Timolol—glaucoma	0.000178	0.000402	CcSEcCtD
Dexmethylphenidate—Body temperature increased—Dorzolamide—glaucoma	0.000178	0.000401	CcSEcCtD
Dexmethylphenidate—Abdominal pain—Dorzolamide—glaucoma	0.000178	0.000401	CcSEcCtD
Dexmethylphenidate—Tension—Betaxolol—glaucoma	0.000177	0.000401	CcSEcCtD
Dexmethylphenidate—Sinusitis—Timolol—glaucoma	0.000177	0.0004	CcSEcCtD
Dexmethylphenidate—Arthralgia—Clonidine—glaucoma	0.000177	0.000399	CcSEcCtD
Dexmethylphenidate—Chest pain—Clonidine—glaucoma	0.000177	0.000399	CcSEcCtD
Dexmethylphenidate—Abdominal pain—Travoprost—glaucoma	0.000177	0.000399	CcSEcCtD
Dexmethylphenidate—Anxiety—Clonidine—glaucoma	0.000176	0.000398	CcSEcCtD
Dexmethylphenidate—Asthenia—Acetazolamide—glaucoma	0.000176	0.000397	CcSEcCtD
Dexmethylphenidate—Dizziness—Bimatoprost—glaucoma	0.000176	0.000397	CcSEcCtD
Dexmethylphenidate—Nervousness—Betaxolol—glaucoma	0.000176	0.000396	CcSEcCtD
Dexmethylphenidate—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	0.000176	0.000396	CcSEcCtD
Dexmethylphenidate—Urticaria—Brinzolamide—glaucoma	0.000175	0.000396	CcSEcCtD
Dexmethylphenidate—Feeling abnormal—Pilocarpine—glaucoma	0.000175	0.000395	CcSEcCtD
Dexmethylphenidate—Discomfort—Clonidine—glaucoma	0.000175	0.000394	CcSEcCtD
Dexmethylphenidate—Vomiting—Apraclonidine—glaucoma	0.000174	0.000393	CcSEcCtD
Dexmethylphenidate—Muscle spasms—Betaxolol—glaucoma	0.000174	0.000392	CcSEcCtD
Dexmethylphenidate—SLC6A3—NRF2 pathway—GSTM1—glaucoma	0.000174	0.00411	CbGpPWpGaD
Dexmethylphenidate—Gastrointestinal pain—Pilocarpine—glaucoma	0.000174	0.000392	CcSEcCtD
Dexmethylphenidate—Hypersensitivity—Brimonidine—glaucoma	0.000173	0.000391	CcSEcCtD
Dexmethylphenidate—Dry mouth—Clonidine—glaucoma	0.000173	0.00039	CcSEcCtD
Dexmethylphenidate—Bradycardia—Timolol—glaucoma	0.000173	0.00039	CcSEcCtD
Dexmethylphenidate—Dermatitis—Apraclonidine—glaucoma	0.000173	0.00039	CcSEcCtD
Dexmethylphenidate—Headache—Apraclonidine—glaucoma	0.000172	0.000387	CcSEcCtD
Dexmethylphenidate—Confusional state—Clonidine—glaucoma	0.000171	0.000386	CcSEcCtD
Dexmethylphenidate—Vision blurred—Betaxolol—glaucoma	0.00017	0.000385	CcSEcCtD
Dexmethylphenidate—Rhinitis—Timolol—glaucoma	0.00017	0.000384	CcSEcCtD
Dexmethylphenidate—Oedema—Clonidine—glaucoma	0.00017	0.000383	CcSEcCtD
Dexmethylphenidate—Tremor—Betaxolol—glaucoma	0.000169	0.000382	CcSEcCtD
Dexmethylphenidate—Hallucination—Timolol—glaucoma	0.000169	0.000381	CcSEcCtD
Dexmethylphenidate—Asthenia—Brimonidine—glaucoma	0.000169	0.000381	CcSEcCtD
Dexmethylphenidate—Infection—Clonidine—glaucoma	0.000168	0.00038	CcSEcCtD
Dexmethylphenidate—CYP2D6—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.000168	0.00398	CbGpPWpGaD
Dexmethylphenidate—Body temperature increased—Pilocarpine—glaucoma	0.000168	0.000379	CcSEcCtD
Dexmethylphenidate—Abdominal pain—Pilocarpine—glaucoma	0.000168	0.000379	CcSEcCtD
Dexmethylphenidate—Ill-defined disorder—Betaxolol—glaucoma	0.000168	0.000379	CcSEcCtD
Dexmethylphenidate—Diarrhoea—Acetazolamide—glaucoma	0.000168	0.000379	CcSEcCtD
Dexmethylphenidate—Rash—Bimatoprost—glaucoma	0.000168	0.000378	CcSEcCtD
Dexmethylphenidate—Dermatitis—Bimatoprost—glaucoma	0.000167	0.000378	CcSEcCtD
Dexmethylphenidate—Anaemia—Betaxolol—glaucoma	0.000167	0.000377	CcSEcCtD
Dexmethylphenidate—Shock—Clonidine—glaucoma	0.000167	0.000376	CcSEcCtD
Dexmethylphenidate—Connective tissue disorder—Timolol—glaucoma	0.000167	0.000376	CcSEcCtD
Dexmethylphenidate—Pruritus—Brimonidine—glaucoma	0.000166	0.000376	CcSEcCtD
Dexmethylphenidate—Headache—Bimatoprost—glaucoma	0.000166	0.000376	CcSEcCtD
Dexmethylphenidate—Nervous system disorder—Clonidine—glaucoma	0.000166	0.000375	CcSEcCtD
Dexmethylphenidate—Thrombocytopenia—Clonidine—glaucoma	0.000166	0.000375	CcSEcCtD
Dexmethylphenidate—Hypersensitivity—Dorzolamide—glaucoma	0.000166	0.000374	CcSEcCtD
Dexmethylphenidate—Tachycardia—Clonidine—glaucoma	0.000165	0.000373	CcSEcCtD
Dexmethylphenidate—Hypersensitivity—Travoprost—glaucoma	0.000165	0.000372	CcSEcCtD
Dexmethylphenidate—Skin disorder—Clonidine—glaucoma	0.000165	0.000372	CcSEcCtD
Dexmethylphenidate—Hyperhidrosis—Clonidine—glaucoma	0.000164	0.00037	CcSEcCtD
Dexmethylphenidate—Visual impairment—Timolol—glaucoma	0.000164	0.000369	CcSEcCtD
Dexmethylphenidate—Malaise—Betaxolol—glaucoma	0.000163	0.000368	CcSEcCtD
Dexmethylphenidate—Nausea—Apraclonidine—glaucoma	0.000163	0.000367	CcSEcCtD
Dexmethylphenidate—Hypersensitivity—Brinzolamide—glaucoma	0.000163	0.000367	CcSEcCtD
Dexmethylphenidate—Vertigo—Betaxolol—glaucoma	0.000162	0.000367	CcSEcCtD
Dexmethylphenidate—Syncope—Betaxolol—glaucoma	0.000162	0.000366	CcSEcCtD
Dexmethylphenidate—Dizziness—Acetazolamide—glaucoma	0.000162	0.000366	CcSEcCtD
Dexmethylphenidate—Anorexia—Clonidine—glaucoma	0.000162	0.000365	CcSEcCtD
Dexmethylphenidate—Asthenia—Dorzolamide—glaucoma	0.000161	0.000364	CcSEcCtD
Dexmethylphenidate—Asthenia—Travoprost—glaucoma	0.000161	0.000362	CcSEcCtD
Dexmethylphenidate—Palpitations—Betaxolol—glaucoma	0.00016	0.000361	CcSEcCtD
Dexmethylphenidate—Pruritus—Dorzolamide—glaucoma	0.000159	0.000359	CcSEcCtD
Dexmethylphenidate—Loss of consciousness—Betaxolol—glaucoma	0.000159	0.000359	CcSEcCtD
Dexmethylphenidate—Eye disorder—Timolol—glaucoma	0.000159	0.000358	CcSEcCtD
Dexmethylphenidate—Asthenia—Brinzolamide—glaucoma	0.000158	0.000358	CcSEcCtD
Dexmethylphenidate—SLC6A4—Circadian rythm related genes—FAS—glaucoma	0.000158	0.00375	CbGpPWpGaD
Dexmethylphenidate—Pruritus—Travoprost—glaucoma	0.000158	0.000357	CcSEcCtD
Dexmethylphenidate—Cough—Betaxolol—glaucoma	0.000158	0.000356	CcSEcCtD
Dexmethylphenidate—Nausea—Bimatoprost—glaucoma	0.000158	0.000356	CcSEcCtD
Dexmethylphenidate—Cardiac disorder—Timolol—glaucoma	0.000158	0.000356	CcSEcCtD
Dexmethylphenidate—Hypersensitivity—Pilocarpine—glaucoma	0.000156	0.000353	CcSEcCtD
Dexmethylphenidate—Pruritus—Brinzolamide—glaucoma	0.000156	0.000353	CcSEcCtD
Dexmethylphenidate—Vomiting—Acetazolamide—glaucoma	0.000156	0.000352	CcSEcCtD
Dexmethylphenidate—Dizziness—Brimonidine—glaucoma	0.000156	0.000351	CcSEcCtD
Dexmethylphenidate—SLC6A2—Transmembrane transport of small molecules—SLC6A13—glaucoma	0.000155	0.00366	CbGpPWpGaD
Dexmethylphenidate—Musculoskeletal discomfort—Clonidine—glaucoma	0.000154	0.000349	CcSEcCtD
Dexmethylphenidate—Angiopathy—Timolol—glaucoma	0.000154	0.000348	CcSEcCtD
Dexmethylphenidate—Myalgia—Betaxolol—glaucoma	0.000154	0.000348	CcSEcCtD
Dexmethylphenidate—Chest pain—Betaxolol—glaucoma	0.000154	0.000348	CcSEcCtD
Dexmethylphenidate—Arthralgia—Betaxolol—glaucoma	0.000154	0.000348	CcSEcCtD
Dexmethylphenidate—Diarrhoea—Dorzolamide—glaucoma	0.000154	0.000347	CcSEcCtD
Dexmethylphenidate—Headache—Acetazolamide—glaucoma	0.000154	0.000347	CcSEcCtD
Dexmethylphenidate—Anxiety—Betaxolol—glaucoma	0.000153	0.000346	CcSEcCtD
Dexmethylphenidate—Insomnia—Clonidine—glaucoma	0.000153	0.000346	CcSEcCtD
Dexmethylphenidate—Immune system disorder—Timolol—glaucoma	0.000153	0.000346	CcSEcCtD
Dexmethylphenidate—Diarrhoea—Travoprost—glaucoma	0.000153	0.000345	CcSEcCtD
Dexmethylphenidate—Mediastinal disorder—Timolol—glaucoma	0.000153	0.000345	CcSEcCtD
Dexmethylphenidate—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	0.000153	0.000345	CcSEcCtD
Dexmethylphenidate—Asthenia—Pilocarpine—glaucoma	0.000152	0.000344	CcSEcCtD
Dexmethylphenidate—Paraesthesia—Clonidine—glaucoma	0.000152	0.000344	CcSEcCtD
Dexmethylphenidate—Discomfort—Betaxolol—glaucoma	0.000152	0.000343	CcSEcCtD
Dexmethylphenidate—Arrhythmia—Timolol—glaucoma	0.000152	0.000342	CcSEcCtD
Dexmethylphenidate—Dyspnoea—Clonidine—glaucoma	0.000151	0.000341	CcSEcCtD
Dexmethylphenidate—Diarrhoea—Brinzolamide—glaucoma	0.000151	0.000341	CcSEcCtD
Dexmethylphenidate—Somnolence—Clonidine—glaucoma	0.000151	0.00034	CcSEcCtD
Dexmethylphenidate—Dry mouth—Betaxolol—glaucoma	0.000151	0.00034	CcSEcCtD
Dexmethylphenidate—Pruritus—Pilocarpine—glaucoma	0.00015	0.000339	CcSEcCtD
Dexmethylphenidate—Alopecia—Timolol—glaucoma	0.00015	0.000338	CcSEcCtD
Dexmethylphenidate—Confusional state—Betaxolol—glaucoma	0.000149	0.000336	CcSEcCtD
Dexmethylphenidate—Mental disorder—Timolol—glaucoma	0.000149	0.000336	CcSEcCtD
Dexmethylphenidate—Dizziness—Dorzolamide—glaucoma	0.000149	0.000335	CcSEcCtD
Dexmethylphenidate—Rash—Brimonidine—glaucoma	0.000148	0.000335	CcSEcCtD
Dexmethylphenidate—Dermatitis—Brimonidine—glaucoma	0.000148	0.000334	CcSEcCtD
Dexmethylphenidate—Dizziness—Travoprost—glaucoma	0.000148	0.000334	CcSEcCtD
Dexmethylphenidate—Malnutrition—Timolol—glaucoma	0.000148	0.000333	CcSEcCtD
Dexmethylphenidate—Erythema—Timolol—glaucoma	0.000148	0.000333	CcSEcCtD
Dexmethylphenidate—Oedema—Betaxolol—glaucoma	0.000148	0.000333	CcSEcCtD
Dexmethylphenidate—Headache—Brimonidine—glaucoma	0.000147	0.000333	CcSEcCtD
Dexmethylphenidate—Decreased appetite—Clonidine—glaucoma	0.000147	0.000333	CcSEcCtD
Dexmethylphenidate—Infection—Betaxolol—glaucoma	0.000147	0.000331	CcSEcCtD
Dexmethylphenidate—Gastrointestinal disorder—Clonidine—glaucoma	0.000146	0.00033	CcSEcCtD
Dexmethylphenidate—Fatigue—Clonidine—glaucoma	0.000146	0.00033	CcSEcCtD
Dexmethylphenidate—Dizziness—Brinzolamide—glaucoma	0.000146	0.00033	CcSEcCtD
Dexmethylphenidate—Nausea—Acetazolamide—glaucoma	0.000146	0.000329	CcSEcCtD
Dexmethylphenidate—Diarrhoea—Pilocarpine—glaucoma	0.000145	0.000328	CcSEcCtD
Dexmethylphenidate—Shock—Betaxolol—glaucoma	0.000145	0.000328	CcSEcCtD
Dexmethylphenidate—Tension—Timolol—glaucoma	0.000145	0.000327	CcSEcCtD
Dexmethylphenidate—Pain—Clonidine—glaucoma	0.000145	0.000327	CcSEcCtD
Dexmethylphenidate—Constipation—Clonidine—glaucoma	0.000145	0.000327	CcSEcCtD
Dexmethylphenidate—Nervous system disorder—Betaxolol—glaucoma	0.000145	0.000327	CcSEcCtD
Dexmethylphenidate—Thrombocytopenia—Betaxolol—glaucoma	0.000145	0.000326	CcSEcCtD
Dexmethylphenidate—Tachycardia—Betaxolol—glaucoma	0.000144	0.000325	CcSEcCtD
Dexmethylphenidate—Nervousness—Timolol—glaucoma	0.000144	0.000324	CcSEcCtD
Dexmethylphenidate—Skin disorder—Betaxolol—glaucoma	0.000143	0.000324	CcSEcCtD
Dexmethylphenidate—Vomiting—Dorzolamide—glaucoma	0.000143	0.000322	CcSEcCtD
Dexmethylphenidate—Hyperhidrosis—Betaxolol—glaucoma	0.000143	0.000322	CcSEcCtD
Dexmethylphenidate—Rash—Dorzolamide—glaucoma	0.000142	0.00032	CcSEcCtD
Dexmethylphenidate—Dermatitis—Dorzolamide—glaucoma	0.000142	0.000319	CcSEcCtD
Dexmethylphenidate—Rash—Travoprost—glaucoma	0.000141	0.000318	CcSEcCtD
Dexmethylphenidate—Dermatitis—Travoprost—glaucoma	0.000141	0.000318	CcSEcCtD
Dexmethylphenidate—Headache—Dorzolamide—glaucoma	0.000141	0.000318	CcSEcCtD
Dexmethylphenidate—Anorexia—Betaxolol—glaucoma	0.000141	0.000318	CcSEcCtD
Dexmethylphenidate—Vomiting—Brinzolamide—glaucoma	0.00014	0.000317	CcSEcCtD
Dexmethylphenidate—Dizziness—Pilocarpine—glaucoma	0.00014	0.000317	CcSEcCtD
Dexmethylphenidate—Headache—Travoprost—glaucoma	0.00014	0.000316	CcSEcCtD
Dexmethylphenidate—Nausea—Brimonidine—glaucoma	0.00014	0.000315	CcSEcCtD
Dexmethylphenidate—Feeling abnormal—Clonidine—glaucoma	0.00014	0.000315	CcSEcCtD
Dexmethylphenidate—Rash—Brinzolamide—glaucoma	0.000139	0.000314	CcSEcCtD
Dexmethylphenidate—Vision blurred—Timolol—glaucoma	0.000139	0.000314	CcSEcCtD
Dexmethylphenidate—Dermatitis—Brinzolamide—glaucoma	0.000139	0.000314	CcSEcCtD
Dexmethylphenidate—Gastrointestinal pain—Clonidine—glaucoma	0.000139	0.000313	CcSEcCtD
Dexmethylphenidate—Headache—Brinzolamide—glaucoma	0.000138	0.000312	CcSEcCtD
Dexmethylphenidate—SLC6A3—Transmembrane transport of small molecules—SLC6A13—glaucoma	0.000137	0.00325	CbGpPWpGaD
Dexmethylphenidate—Angioedema—Timolol—glaucoma	0.000135	0.000305	CcSEcCtD
Dexmethylphenidate—Vomiting—Pilocarpine—glaucoma	0.000135	0.000305	CcSEcCtD
Dexmethylphenidate—Urticaria—Clonidine—glaucoma	0.000135	0.000304	CcSEcCtD
Dexmethylphenidate—Musculoskeletal discomfort—Betaxolol—glaucoma	0.000134	0.000304	CcSEcCtD
Dexmethylphenidate—Body temperature increased—Clonidine—glaucoma	0.000134	0.000302	CcSEcCtD
Dexmethylphenidate—Abdominal pain—Clonidine—glaucoma	0.000134	0.000302	CcSEcCtD
Dexmethylphenidate—Rash—Pilocarpine—glaucoma	0.000134	0.000302	CcSEcCtD
Dexmethylphenidate—Dermatitis—Pilocarpine—glaucoma	0.000134	0.000302	CcSEcCtD
Dexmethylphenidate—Insomnia—Betaxolol—glaucoma	0.000134	0.000301	CcSEcCtD
Dexmethylphenidate—Nausea—Dorzolamide—glaucoma	0.000133	0.000301	CcSEcCtD
Dexmethylphenidate—Headache—Pilocarpine—glaucoma	0.000133	0.0003	CcSEcCtD
Dexmethylphenidate—Nausea—Travoprost—glaucoma	0.000133	0.0003	CcSEcCtD
Dexmethylphenidate—Vertigo—Timolol—glaucoma	0.000133	0.0003	CcSEcCtD
Dexmethylphenidate—Paraesthesia—Betaxolol—glaucoma	0.000133	0.000299	CcSEcCtD
Dexmethylphenidate—Syncope—Timolol—glaucoma	0.000133	0.000299	CcSEcCtD
Dexmethylphenidate—Dyspnoea—Betaxolol—glaucoma	0.000132	0.000297	CcSEcCtD
Dexmethylphenidate—Nausea—Brinzolamide—glaucoma	0.000131	0.000296	CcSEcCtD
Dexmethylphenidate—Palpitations—Timolol—glaucoma	0.000131	0.000295	CcSEcCtD
Dexmethylphenidate—Dyspepsia—Betaxolol—glaucoma	0.00013	0.000293	CcSEcCtD
Dexmethylphenidate—Loss of consciousness—Timolol—glaucoma	0.00013	0.000293	CcSEcCtD
Dexmethylphenidate—Cough—Timolol—glaucoma	0.000129	0.000291	CcSEcCtD
Dexmethylphenidate—Decreased appetite—Betaxolol—glaucoma	0.000128	0.00029	CcSEcCtD
Dexmethylphenidate—Hypertension—Timolol—glaucoma	0.000128	0.000288	CcSEcCtD
Dexmethylphenidate—Gastrointestinal disorder—Betaxolol—glaucoma	0.000127	0.000288	CcSEcCtD
Dexmethylphenidate—Fatigue—Betaxolol—glaucoma	0.000127	0.000287	CcSEcCtD
Dexmethylphenidate—Pain—Betaxolol—glaucoma	0.000126	0.000285	CcSEcCtD
Dexmethylphenidate—Constipation—Betaxolol—glaucoma	0.000126	0.000285	CcSEcCtD
Dexmethylphenidate—Nausea—Pilocarpine—glaucoma	0.000126	0.000285	CcSEcCtD
Dexmethylphenidate—Chest pain—Timolol—glaucoma	0.000126	0.000284	CcSEcCtD
Dexmethylphenidate—Arthralgia—Timolol—glaucoma	0.000126	0.000284	CcSEcCtD
Dexmethylphenidate—Myalgia—Timolol—glaucoma	0.000126	0.000284	CcSEcCtD
Dexmethylphenidate—Anxiety—Timolol—glaucoma	0.000125	0.000283	CcSEcCtD
Dexmethylphenidate—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	0.000125	0.000282	CcSEcCtD
Dexmethylphenidate—Hypersensitivity—Clonidine—glaucoma	0.000125	0.000282	CcSEcCtD
Dexmethylphenidate—Discomfort—Timolol—glaucoma	0.000124	0.00028	CcSEcCtD
Dexmethylphenidate—Dry mouth—Timolol—glaucoma	0.000123	0.000278	CcSEcCtD
Dexmethylphenidate—Asthenia—Clonidine—glaucoma	0.000122	0.000275	CcSEcCtD
Dexmethylphenidate—Feeling abnormal—Betaxolol—glaucoma	0.000122	0.000275	CcSEcCtD
Dexmethylphenidate—Confusional state—Timolol—glaucoma	0.000122	0.000274	CcSEcCtD
Dexmethylphenidate—Anaphylactic shock—Timolol—glaucoma	0.000121	0.000272	CcSEcCtD
Dexmethylphenidate—Oedema—Timolol—glaucoma	0.000121	0.000272	CcSEcCtD
Dexmethylphenidate—Pruritus—Clonidine—glaucoma	0.00012	0.000271	CcSEcCtD
Dexmethylphenidate—Infection—Timolol—glaucoma	0.00012	0.00027	CcSEcCtD
Dexmethylphenidate—Shock—Timolol—glaucoma	0.000119	0.000268	CcSEcCtD
Dexmethylphenidate—Nervous system disorder—Timolol—glaucoma	0.000118	0.000267	CcSEcCtD
Dexmethylphenidate—Urticaria—Betaxolol—glaucoma	0.000117	0.000265	CcSEcCtD
Dexmethylphenidate—Skin disorder—Timolol—glaucoma	0.000117	0.000264	CcSEcCtD
Dexmethylphenidate—Body temperature increased—Betaxolol—glaucoma	0.000117	0.000263	CcSEcCtD
Dexmethylphenidate—Hyperhidrosis—Timolol—glaucoma	0.000117	0.000263	CcSEcCtD
Dexmethylphenidate—Diarrhoea—Clonidine—glaucoma	0.000116	0.000262	CcSEcCtD
Dexmethylphenidate—Anorexia—Timolol—glaucoma	0.000115	0.000259	CcSEcCtD
Dexmethylphenidate—SLC6A2—Transmembrane transport of small molecules—SLC6A1—glaucoma	0.000113	0.00268	CbGpPWpGaD
Dexmethylphenidate—Dizziness—Clonidine—glaucoma	0.000112	0.000253	CcSEcCtD
Dexmethylphenidate—CYP2D6—Biological oxidations—GSTT1—glaucoma	0.000112	0.00265	CbGpPWpGaD
Dexmethylphenidate—Musculoskeletal discomfort—Timolol—glaucoma	0.00011	0.000248	CcSEcCtD
Dexmethylphenidate—Insomnia—Timolol—glaucoma	0.000109	0.000246	CcSEcCtD
Dexmethylphenidate—Hypersensitivity—Betaxolol—glaucoma	0.000109	0.000245	CcSEcCtD
Dexmethylphenidate—Paraesthesia—Timolol—glaucoma	0.000108	0.000244	CcSEcCtD
Dexmethylphenidate—Vomiting—Clonidine—glaucoma	0.000108	0.000243	CcSEcCtD
Dexmethylphenidate—Dyspnoea—Timolol—glaucoma	0.000108	0.000243	CcSEcCtD
Dexmethylphenidate—Somnolence—Timolol—glaucoma	0.000107	0.000242	CcSEcCtD
Dexmethylphenidate—Rash—Clonidine—glaucoma	0.000107	0.000241	CcSEcCtD
Dexmethylphenidate—Dermatitis—Clonidine—glaucoma	0.000107	0.000241	CcSEcCtD
Dexmethylphenidate—Headache—Clonidine—glaucoma	0.000106	0.00024	CcSEcCtD
Dexmethylphenidate—Dyspepsia—Timolol—glaucoma	0.000106	0.00024	CcSEcCtD
Dexmethylphenidate—Asthenia—Betaxolol—glaucoma	0.000106	0.000239	CcSEcCtD
Dexmethylphenidate—Decreased appetite—Timolol—glaucoma	0.000105	0.000237	CcSEcCtD
Dexmethylphenidate—Pruritus—Betaxolol—glaucoma	0.000104	0.000236	CcSEcCtD
Dexmethylphenidate—Gastrointestinal disorder—Timolol—glaucoma	0.000104	0.000235	CcSEcCtD
Dexmethylphenidate—Fatigue—Timolol—glaucoma	0.000104	0.000235	CcSEcCtD
Dexmethylphenidate—Pain—Timolol—glaucoma	0.000103	0.000233	CcSEcCtD
Dexmethylphenidate—Diarrhoea—Betaxolol—glaucoma	0.000101	0.000228	CcSEcCtD
Dexmethylphenidate—Nausea—Clonidine—glaucoma	0.000101	0.000227	CcSEcCtD
Dexmethylphenidate—SLC6A3—Transmembrane transport of small molecules—SLC6A1—glaucoma	0.0001	0.00238	CbGpPWpGaD
Dexmethylphenidate—Feeling abnormal—Timolol—glaucoma	9.94e-05	0.000224	CcSEcCtD
Dexmethylphenidate—Gastrointestinal pain—Timolol—glaucoma	9.86e-05	0.000223	CcSEcCtD
Dexmethylphenidate—Dizziness—Betaxolol—glaucoma	9.76e-05	0.00022	CcSEcCtD
Dexmethylphenidate—SLC6A4—SIDS Susceptibility Pathways—VEGFA—glaucoma	9.61e-05	0.00227	CbGpPWpGaD
Dexmethylphenidate—Urticaria—Timolol—glaucoma	9.58e-05	0.000216	CcSEcCtD
Dexmethylphenidate—Body temperature increased—Timolol—glaucoma	9.53e-05	0.000215	CcSEcCtD
Dexmethylphenidate—Abdominal pain—Timolol—glaucoma	9.53e-05	0.000215	CcSEcCtD
Dexmethylphenidate—Vomiting—Betaxolol—glaucoma	9.39e-05	0.000212	CcSEcCtD
Dexmethylphenidate—Rash—Betaxolol—glaucoma	9.31e-05	0.00021	CcSEcCtD
Dexmethylphenidate—Dermatitis—Betaxolol—glaucoma	9.3e-05	0.00021	CcSEcCtD
Dexmethylphenidate—Headache—Betaxolol—glaucoma	9.25e-05	0.000209	CcSEcCtD
Dexmethylphenidate—CYP2D6—Biological oxidations—CYP1B1—glaucoma	8.93e-05	0.00211	CbGpPWpGaD
Dexmethylphenidate—Hypersensitivity—Timolol—glaucoma	8.88e-05	0.000201	CcSEcCtD
Dexmethylphenidate—CYP2D6—Metapathway biotransformation—CYP1B1—glaucoma	8.81e-05	0.00208	CbGpPWpGaD
Dexmethylphenidate—Nausea—Betaxolol—glaucoma	8.77e-05	0.000198	CcSEcCtD
Dexmethylphenidate—Asthenia—Timolol—glaucoma	8.65e-05	0.000195	CcSEcCtD
Dexmethylphenidate—Pruritus—Timolol—glaucoma	8.53e-05	0.000193	CcSEcCtD
Dexmethylphenidate—Diarrhoea—Timolol—glaucoma	8.25e-05	0.000186	CcSEcCtD
Dexmethylphenidate—SLC6A4—SIDS Susceptibility Pathways—TNF—glaucoma	8.23e-05	0.00195	CbGpPWpGaD
Dexmethylphenidate—Dizziness—Timolol—glaucoma	7.97e-05	0.00018	CcSEcCtD
Dexmethylphenidate—CYP2D6—Metabolism—CA5A—glaucoma	7.85e-05	0.00186	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—NARFL—glaucoma	7.85e-05	0.00186	CbGpPWpGaD
Dexmethylphenidate—Vomiting—Timolol—glaucoma	7.67e-05	0.000173	CcSEcCtD
Dexmethylphenidate—Rash—Timolol—glaucoma	7.6e-05	0.000172	CcSEcCtD
Dexmethylphenidate—Dermatitis—Timolol—glaucoma	7.6e-05	0.000171	CcSEcCtD
Dexmethylphenidate—Headache—Timolol—glaucoma	7.55e-05	0.00017	CcSEcCtD
Dexmethylphenidate—Nausea—Timolol—glaucoma	7.16e-05	0.000162	CcSEcCtD
Dexmethylphenidate—CYP2D6—Biological oxidations—GSTM1—glaucoma	7.14e-05	0.00169	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metapathway biotransformation—GSTM1—glaucoma	7.04e-05	0.00167	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—Circadian rythm related genes—TP53—glaucoma	5.93e-05	0.0014	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—CA1—glaucoma	3.84e-05	0.000907	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—CTSA—glaucoma	3.71e-05	0.000879	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—CA2—glaucoma	3.51e-05	0.00083	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—TXN—glaucoma	2.47e-05	0.000585	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—GSTT1—glaucoma	1.92e-05	0.000453	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—CYP1B1—glaucoma	1.53e-05	0.000361	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—ABCA1—glaucoma	1.53e-05	0.000361	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—GSTM1—glaucoma	1.22e-05	0.000289	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—MTHFR—glaucoma	1.08e-05	0.000255	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—APOE—glaucoma	1e-05	0.000238	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—CAV1—glaucoma	9.95e-06	0.000235	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—NOS3—glaucoma	7.52e-06	0.000178	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—PTGS2—glaucoma	6.88e-06	0.000163	CbGpPWpGaD
